SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (3174)12/7/2020 5:35:29 PM
From: A.J. Mullen  Read Replies (2) | Respond to of 3557
 
Those results look good to me, but I see a number of companies reported encouraging results at ASH, barrons.com.


“Competition for BCMA is fierce but we think there is space for multiple players,” RBC Capital Markets analyst Luca Issi wrote in a Sunday note. He hopes that the different ways the BCMA treatments are delivered will lead to a segmented market. Good news for patients



To: Miljenko Zuanic who wrote (3174)12/8/2020 4:56:08 PM
From: Miljenko Zuanic  Respond to of 3557
 
wow, it is positive today!
Is it raining out (here in CA)?



To: Miljenko Zuanic who wrote (3174)12/16/2020 4:30:29 AM
From: Biotechwantabe  Read Replies (1) | Respond to of 3557
 
today.westlaw.com

I thought Trump was a republican? Must be fake news.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News